Cardiac Allograft Vasculopathy

Author:

Hosenpud Jeffrey D.1,Everett John P.1,Morris Tony E.1,Mauck Kimberly A.1,Shipley Gary D.1,Wagner Cynthia R.1

Affiliation:

1. From the Immunobiology Research Laboratory of the Oregon Cardiac Transplant Program; Departments of Medicine and Cell Biology and Anatomy, Oregon Health Sciences University; and Immunology Research, Portland Veterans Affairs Medical Center, Portland, Ore.

Abstract

Background Cardiac allograft vasculopathy (CAV) is an accelerated form of coronary artery disease responsible for the majority of late deaths after cardiac transplantation. Although most consider this complication a manifestation of chronic allograft rejection, it has not been established whether this disease is a consequence of humoral or cell-mediated alloreactivity. Methods and Results Human aortic endothelial cells (HAECs) were isolated from donor aortas obtained at the time of organ acquisition for 52 cardiac allograft recipients. Serum and peripheral blood mononuclear cells were obtained from these 52 allograft recipients at several time points during the first year after transplantation. Lymphocyte proliferation (LP) in response to donor-specific HAECs and alloantibody binding to interferon-γ–treated donor-specific HAECs were performed and correlated with clinical parameters, including HLA matching, acute cellular rejection, and coronary artery disease on surveillance angiography. Ten of the 52 patients studied had angiographic or autopsy evidence of coronary artery disease in the first posttransplantation year (CAV+ group). The CAV+ group had higher LP responses to their donor HAECs at 1 week, 3 months, and 6 months after transplantation compared with the CAV− group (1 week: 1439±222 versus 824±141 counts per minute [cpm], P =.026; 3 months: 1282±388 versus 884±94 cpm, P =.07; 6 months: 2504±635 versus 1540±209 cpm, P =.036; CAV+ versus CAV−, respectively). Only 8 of the 52 patients had donor-specific alloantibodies, and there was no relation between antibody presence and CAV. Other clinical parameters that correlated with CAV included the level of HLA-DR mismatch and the presence of late acute rejection. Conclusions CAV is associated with donor-specific cell-mediated alloreactivity to vascular endothelium. Humoral immunity does not appear to have a major role in this disease.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference59 articles.

1. Gao SZ Schroeder JS Alderman EL et al. Prevalence of accelerated coronary artery disease in heart transplant survivors. Circulation . 1989;80(suppl III):III-100-III-105.

2. Porter KA Owen K Mowbray JF Thomson WB Kenyon JR Peart WS. Obliterative vascular changes in four human kidney homotransplants. Br Med J . 1963;Sep 14:639-645.

3. Pathologic pulmonary alterations in long-term human heart-lung transplantation

Cited by 79 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Cardiac Transplantation;Disorders of the Heart and Blood Vessels;2023-11-15

2. Heart Transplant Human Leukocyte Antigen Matching in the Modern Era;Journal of Cardiac Failure;2023-07

3. Review of heart transplantation from hepatitis C-positive donors;World Journal of Transplantation;2022-12-18

4. Effect of Cold Preservation on Chronic Rejection in a Rat Hindlimb Transplantation Model;Plastic and Reconstructive Surgery;2016-09

5. The challenge of allograft vasculopathy in cardiac transplantation;Current Opinion in Organ Transplantation;2014-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3